Treatment.com AI Completes Acquisition of Rocket Doctor Inc.
Treatment.com AI Completes Acquisition of Rocket Doctor Inc.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) is excited to announce the successful completion of its acquisition of Rocket Doctor Inc. This significant step follows a previous announcement and is part of Treatment's ongoing strategy to revolutionize the healthcare industry through innovative technology. The acquisition deals with 100% of Rocket Doctor's issued and outstanding securities, as set forth in a Share Purchase Agreement.
Transforming Healthcare Delivery
Rocket Doctor is known for its dedication to reshaping healthcare by empowering doctors to establish their own virtual practices. This innovation allows patients to have swift access to comprehensive medical care powered by advanced technologies. The approach targets inefficiencies present within traditional healthcare systems, making it easier for patients to receive tailored services, especially in remote areas.
Leadership Insights
Dr. Essam Hamza, CEO of Treatment.com AI, expressed his enthusiasm upon welcoming the Rocket Doctor team. The collaboration promises to optimize patient onboarding and triage with Treatment’s planned AI Nurse. This innovative tool is designed to enhance operational efficiency for practitioners utilizing the Rocket Doctor platform.
Dr. William Cherniak, Co-founder of Rocket Doctor, also shared his excitement regarding this partnership. Both teams have recognized the extraordinary skills and aptitudes brought to the table, emphasizing a shared vision to improve patient and physician experiences using cutting-edge technology in today's AI landscape.
Transaction Details
The acquisition involved significant financial elements, including Treatment satisfying payment obligations under Rocket Doctor’s simple agreement for future equity (SAFE). Treatment offered common shares valued at approximately USD$7,688,640 as part of the initial payment, with further potential shares subject to milestones reached in the following years.
Future Considerations
For those involved in the transaction, it's essential to note that the shares issued will be held in escrow for specific durations to ensure stability and compliance with regulatory requirements. The Company also has committed to issuing stock options and restricted share units to key employees of Rocket Doctor, fostering a unified and motivated team.
About Treatment.com AI Inc.
Treatment.com AI is an innovative company leveraging artificial intelligence to enhance the healthcare landscape. The company’s Global Library of Medicine (GLM) is built with contributions from numerous healthcare professionals and possesses a wealth of clinical knowledge. This resource allows healthcare providers to minimize their administrative workload and focus more on patient interactions.
About Rocket Doctor Inc.
Rocket Doctor aims to navigate barriers to quality healthcare access. Utilizing AI, machine learning, and wireless devices, Rocket Doctor connects patients to crucial healthcare services promptly and effectively. The platform is particularly beneficial for underserved populations, ensuring that everyone has access to necessary care regardless of their geographic or socio-economic status.
Contact Information
For further details, please reach out to Dr. Essam Hamza, CEO of Treatment.com AI at ehamza@treatment.com. Interested parties can also call the office at +1 (612) 788-8900 or toll-free in the USA and Canada at +1 (888) 788-8955.
Frequently Asked Questions
What is the key outcome of this acquisition?
The acquisition aims to enhance healthcare service delivery through advanced technology and AI integration.
What does Rocket Doctor specialize in?
Rocket Doctor provides a digital health platform that allows doctors to operate virtual practices efficiently.
How does Treatment.com AI plan to utilize Rocket Doctor's technology?
Treatment.com AI plans to enhance patient onboarding and triage experiences using its AI Nurse alongside Rocket Doctor's systems.
What are the benefits for patients?
Patients can expect quicker access to comprehensive medical care, especially in underserved areas.
Who can be contacted for more information?
For details, contact Dr. Essam Hamza or visit the Treatment.com AI website.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.